← Back to Search

Radioisotope Therapy

ACTInium-J591 Radionuclide Therapy in PSMA-Detected Metastatic HOrmone-Sensitive Recurrent Prostate CaNcer (ACTION Trial)

Phase 1
Waitlist Available
Led By Himanshu Nagar, M.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new treatment that combines a special drug called Actinium-J591 with either radiation or hormone therapy. It targets patients with prostate cancer that has spread but is not clearly visible on regular scans. The drug helps make the treatments more effective by directly targeting the cancer cells.

Eligible Conditions
  • Hormone-Refractory Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dose Limiting Toxicity (DLT) Rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Cohort 1Active Control2 Interventions
Group II: Cohort 2Active Control2 Interventions

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,091 Previous Clinical Trials
1,154,745 Total Patients Enrolled
50 Trials studying Prostate Cancer
34,657 Patients Enrolled for Prostate Cancer
Convergent Therapeutics, Inc.UNKNOWN
Himanshu Nagar, M.D.Principal InvestigatorWeill Medical College of Cornell University
6 Previous Clinical Trials
517 Total Patients Enrolled
4 Trials studying Prostate Cancer
505 Patients Enrolled for Prostate Cancer
~0 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top